ICU Medical (NASDAQ:ICUI) Downgraded by BidaskClub to “Hold”

BidaskClub cut shares of ICU Medical (NASDAQ:ICUI) from a buy rating to a hold rating in a research note issued to investors on Wednesday, BidAskClub reports.

ICUI has been the topic of several other research reports. ValuEngine cut ICU Medical from a hold rating to a sell rating in a report on Thursday, August 8th. Raymond James cut ICU Medical from a strong-buy rating to an outperform rating in a report on Thursday, August 8th. TheStreet raised ICU Medical from a c+ rating to a b rating in a report on Friday, May 10th. Finally, Zacks Investment Research cut ICU Medical from a hold rating to a sell rating in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $290.50.

NASDAQ:ICUI traded up $0.05 during midday trading on Wednesday, hitting $164.75. 4,458 shares of the stock were exchanged, compared to its average volume of 289,385. ICU Medical has a one year low of $160.00 and a one year high of $312.45. The company has a market cap of $3.50 billion, a P/E ratio of 21.44 and a beta of 0.81. The company’s 50-day moving average price is $239.12.



ICU Medical (NASDAQ:ICUI) last announced its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.99 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.86 by $0.13. ICU Medical had a return on equity of 12.41% and a net margin of 3.56%. The firm had revenue of $312.30 million for the quarter, compared to analysts’ expectations of $315.47 million. The firm’s quarterly revenue was down 13.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.69 earnings per share. Research analysts anticipate that ICU Medical will post 7.21 earnings per share for the current year.

In other news, Director Robert S. Swinney sold 239 shares of the business’s stock in a transaction on Monday, July 15th. The shares were sold at an average price of $248.73, for a total transaction of $59,446.47. Following the transaction, the director now directly owns 19,662 shares in the company, valued at approximately $4,890,529.26. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Kevin J. Mcgrody sold 7,344 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $231.68, for a total transaction of $1,701,457.92. Following the transaction, the insider now owns 7,574 shares in the company, valued at $1,754,744.32. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,583 shares of company stock worth $8,010,904. 11.40% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of ICUI. Price T Rowe Associates Inc. MD grew its holdings in shares of ICU Medical by 22.6% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 3,478,883 shares of the medical instruments supplier’s stock valued at $876,365,000 after acquiring an additional 640,425 shares in the last quarter. Findlay Park Partners LLP purchased a new position in shares of ICU Medical during the 2nd quarter valued at $75,573,000. Janus Henderson Group PLC grew its holdings in shares of ICU Medical by 5.2% during the 2nd quarter. Janus Henderson Group PLC now owns 2,825,836 shares of the medical instruments supplier’s stock valued at $711,856,000 after acquiring an additional 140,123 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of ICU Medical by 41.5% during the 2nd quarter. Wells Fargo & Company MN now owns 418,889 shares of the medical instruments supplier’s stock valued at $105,522,000 after acquiring an additional 122,856 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in shares of ICU Medical by 28.1% during the 2nd quarter. Invesco Ltd. now owns 428,233 shares of the medical instruments supplier’s stock valued at $107,876,000 after acquiring an additional 93,904 shares in the last quarter. Institutional investors and hedge funds own 91.31% of the company’s stock.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: What does a bar chart display?

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.